Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Quarterly results Acq. announced CC transcript Employment agrmnt Coll. bargaining agrmnt Director departure
|
NOVELION THERAPEUTICS INC. (NVLNF)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/12/2019 |
4
| STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Bought 5,202 shares
@ $0.6916, valued at
$3.6k
Bought 40 shares
@ $0.69, valued at
$27.6 Bought 1,000 shares
@ $0.7, valued at
$700 |
|
12/09/2019 |
4
| STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Bought 5,160 shares
@ $0.7, valued at
$3.6k
Bought 40 shares
@ $0.7, valued at
$28 Bought 4,500 shares
@ $0.7, valued at
$3.2k
|
|
11/26/2019 |
4
| STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Bought 89,845 shares
@ $0.7461, valued at
$67k
|
|
10/16/2019 |
4
| STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Bought 100,000 shares
@ $0.649, valued at
$64.9k
|
|
09/26/2019 |
4
| PRICE MICHAEL DENNIS (CFO) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 3,926 shares
@ $0.76, valued at
$3k
|
|
09/26/2019 |
4
| Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 1,688 shares
@ $0.76, valued at
$1.3k
|
|
05/13/2019 |
4
| Louis Roger (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 155 shares
@ $1.22, valued at
$189.1 |
|
05/13/2019 |
4
| Buono Linda (Sr. VP, Human Resources) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 77 shares
@ $1.22, valued at
$93.9 |
|
05/13/2019 |
4
| Harshbarger Benjamin (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 212 shares
@ $1.22, valued at
$258.6 |
|
03/19/2019 |
4
| Chan Barbara Y (See remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 996 shares
@ $1.26, valued at
$1.3k
|
|
12/27/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Sold 400 shares
@ $0.98, valued at
$392 Sold 1,200 shares
@ $0.9325, valued at
$1.1k
Sold 83,245 shares
@ $0.9784, valued at
$81.4k
Sold 12,450 shares
@ $0.9078, valued at
$11.3k
Sold 109,900 shares
@ $0.872, valued at
$95.8k
Sold 12,219 shares
@ $0.9091, valued at
$11.1k
Sold 28,745 shares
@ $0.9058, valued at
$26k
Sold 30,726 shares
@ $0.907, valued at
$27.9k
Sold 14,800 shares
@ $0.8803, valued at
$13k
Sold 56,316 shares
@ $0.8548, valued at
$48.1k
Sold 100,000 shares
@ $0.8514, valued at
$85.1k
|
|
12/10/2018 |
4
| Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 3,313 shares
@ $1.28, valued at
$4.2k
|
|
11/28/2018 |
4
| PRICE MICHAEL DENNIS (CFO) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 1,963 shares
@ $0.92, valued at
$1.8k
|
|
11/05/2018 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 322 shares
@ $4.26, valued at
$1.4k
Paid exercise price by delivering 150 shares
@ $4.15, valued at
$622.5 Paid exercise price by delivering 98 shares
@ $3.94, valued at
$386.1 |
|
11/05/2018 |
4
| HACKMAN JEFFREY (C.O.O. and Interim C.E.O.) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 32,149 shares
@ $0.8971, valued at
$28.8k
|
|
08/27/2018 |
4
| Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 50,000 options to buy
@ $0 |
|
08/13/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Gifted 10,000 options to buy
@ $0 |
|
08/13/2018 |
4
| DiPaolo Mark (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
08/13/2018 |
4
| ORLOFF JOHN J (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
08/13/2018 |
4
| Sabba Stephen L (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
08/13/2018 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
08/13/2018 |
4
| Stern Donald K (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
08/13/2018 |
4
| Thomas John C (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
08/13/2018 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 50,000 options to buy
@ $0 |
|
05/11/2018 |
4
| Louis Roger (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 161 shares
@ $4.26, valued at
$685.9 |
|
05/11/2018 |
4
| Buono Linda (Sr. VP, Human Resources) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 80 shares
@ $4.26, valued at
$340.8 |
|
04/03/2018 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 52 shares
@ $3.5, valued at
$182 |
|
03/26/2018 |
4
| Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 8,600 shares
@ $0 Granted 40,000 options to buy
@ $0 |
|
03/19/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 909,296 warrants
@ $4.4, valued at
$4M
|
|
02/14/2018 |
4
| Stewart Murray (Executive Vice President, R&D) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 45,000 options to buy
@ $0 |
|
02/14/2018 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 45,000 options to buy
@ $0 |
|
02/14/2018 |
4
| Louis Roger (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 25,000 options to buy
@ $0 |
|
02/14/2018 |
4
| Buono Linda (Sr. VP, Human Resources) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 25,000 options to buy
@ $0 |
|
12/08/2017 |
4
| Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 1,216 shares
@ $3.33, valued at
$4k
|
|
|
|
|